The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...
Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...
The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and the insulins Fiasp and NovoLog. Medicare will announce the next 15 drugs by Feb. 1 and ...
State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.
The first round of Medicare prescription drugs negotiations covered Eliquis, Enbrel, Entresto, Farxiga, Fiasp/NovoLog; Imbruvica, Januvia, Jardiance, Stelara and Xarelto. Lower prices of those ...
Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals that distract from ...